Trade

Sunrest Lifescience share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • 53.00(0.00%)
    July 17, 2025 16:00:00 PM IST
    • NSE
    • BSE
  • Vol : 0 (NSE + BSE)
    Last 20 day avg : 16.40 K

Sunrest Lifescience is trading 0.00% upper at Rs 53.00 as compared to its last closing price. Sunrest Lifescience has been trading in the price range of 0.00 & 0.00. Sunrest Lifescience has given 2.91% in this year & 5.16% in the last 5 days. Listed peers of Sunrest Lifescience include Jiwanram Sheoduttrai Industries (-%), Maks Energy Solutions India (1.95%), Sunrest Lifescience (-%).The Mutual Fund holding in Sunrest Lifescience was at -% in . The MF holding has - from the last quarter. The FII holding in Sunrest Lifescience was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 19, 2025, 11:05 AM UTC

  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.37
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.74
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
0.00
Highest
0.00
52 week range
Lowest
44.60
Highest
75.00
Sunrest Lifescience Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    No Data
    Financial insights for Sunrest Lifescience are currently unavailable
    Please check back later.
Sunrest Lifescience Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 54.22
  • R2
  • 57.98
  • R3
  • 59.97
Pivot52.23
  • S1
  • 48.47
  • S2
  • 46.48
  • S3
  • 42.72
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Sunrest Lifescience Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Jiwanram Sheoduttrai Industries
Bearish
8.45-20.917.290.37-48.51
Maks Energy Solutions India
Bearish
31.401.9521.7832.871.42--
Sunrest Lifescience
Neutral
53.00-22.7411.561.42-35.15
Quality Foils India
Bearish
65.20-4.9618.6143.100.73-70.38
Boss Packaging Solutions
Bullish
49.70-0.2022.1012.281.56-0.18
Sunrest Lifescience Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Sunrest Lifescience is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 69.91%
    • InsightsFIIs are not invested in this company
    • InsightsMutual Funds are not invested in this company.
    Sunrest Lifescience Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-30Audited Results
    2025-05-27Audited Results
    2024-11-14Quarterly Results
    2024-05-27Audited Results
    About the company Sunrest Lifescience
    • Industry
    • ISININE0PLZ01012
    • BSE Code
    • NSE CodeSUNREST
    Sunrest Lifescience Limited is an India-based pharmaceutical company. The Company is engaged in the marketing of over the counter (OTC) generic pharmaceutical products manufactured by third party manufacturers in the domestic market. It deals in capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders, and toothpaste. The Company’s product portfolio comprises a range of drugs like Anti-Bacterial, Anti-Diarrheal, Antifungal, Anti Malerial, Anti-Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti-Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory. The Company operates in different states of India, such as Maharashtra, Gujarat, Madhya Pradesh, Odisha, and Rajasthan. The Company works on a third-party manufacturing basis or at times a purchase order basis with manufacturers of pharma products, depending upon the customer’s requirements.
    • Management Info
    • Meha ParekhChief Financial Officer
    • Nishi ShahCompliance Officer, Company Secretary
    • Nikhilkumar ThakkarManaging Director, Executive Director
    • Amitbhai ThakkarWhole Time Director
    • Bharatkumar ThakkarExecutive Director
    • Dhaval SoniNational Sale Manager
    Sunrest Lifescience Share Price FAQs

    Sunrest Lifescience is trading at 53.00 as on Thu Jul 17 2025 10:30:00. This is 0.00% upper as compared to its previous closing price of 53.00.

    The market capitalization of Sunrest Lifescience is 22.74 Cr as on Thu Jul 17 2025 10:30:00.

    The 52 wk high for Sunrest Lifescience is 75.00 whereas the 52 wk low is 44.60

    Sunrest Lifescience can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: 25.87
    • Dividend Yield: %
    • D/E ratio: 0.74

    Sunrest Lifescience reported a net profit of 2.01 Cr in 2025.